About this trial
The study investigates how the COVID-19 pandemic has impacted the psychological, financial, physical, and social well-being of adolescent and young adult (AYA) cancer patients and survivors. AYA cancer survivors have inferior long-term survival compared to the general population, and the negative impact of the global COVID-19 pandemic may be even higher in this vulnerable group. The information gained from this study may provide an opportunity to determine the self-reported COVID-19 specific psychological distress in AYA cancer survivors, and may lead to the development of a targeted intervention to improve physical and psychosocial health for AYA cancer patients and survivors.
Eligibility criteria
Qualifiers
Initial cancer diagnosis between the ages of 15 to 39
Received any cancer treatment at MD Anderson Cancer Center with data available in the MD Anderson Cancer Center Tumor Registry
For questionnaire provision: confirmed alive at time of contact
Disqualifiers
Inability to complete questionnaires in English
Seen at MD Anderson for a second opinion or non-treatment related visit
Trial design
Treatments tested in this trial
- Quality-of-Life Assessment
- Survey Administration
Treatment groups
Locations
1Sponsors and collaborators
M.D. Anderson Cancer Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator